Because it's often difficult to detect genital warts, your doctor may apply a mild acetic acid solution to your genitals to whiten any warts. Then, he or she may view them through a special magnifying instrument, a colposcope.
For women, it's important to have regular pelvic exams and Pap tests, which can help detect vaginal and cervical changes caused by genital warts or the early signs of cervical cancer — a possible complication of genital HPV infection.
During a Pap test, your doctor will use a device called a speculum to hold open your vagina. He or she will then use a long-handled tool to collect a small sample of cells from your cervix — the passage between your vagina and your uterus. The cells are examined with a microscope for abnormalities.
Only a few types of genital HPV have been linked to cervical cancer. A sample of cervical cells, taken during a Pap test, can be tested for these cancer-causing HPV strains.
This test is generally reserved for women ages 30 and older. It isn't as useful for younger women because their immune systems usually can kill even cancer-causing varieties of genital HPV without treatment.
Jan. 02, 2014
- Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5th ed. Edinburgh, U.K.; New York, N.Y.: Mosby Elsevier; 2010. https://www.clinicalkey.com. Accessed Sept. 5, 2013.
- Genital HPV infection: Fact sheet. Centers for Disease Control and Prevention. http://www.cdc.gov/std/HPV/STDFact-HPV.htm. Accessed Sept. 5, 2013.
- Breen E, et al. Condylomata acuminata (anogenital warts). http://www.uptodate.com/home. Accessed Sept. 5, 2013.
- Goldman L, et al. Goldman's Cecil Medicine. 24th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. https://www.clinicalkey.com. Accessed Sept. 5, 2013.
- Making sense of your Pap and HPV test results. Centers for Disease Control and Prevention. http://www.cdc.gov/std/hpv/pap/default.htm. Accessed Sept. 5, 2013.
- Frequently asked questions: Special procedures — Cervical cancer screening. American Congress of Obstetricians and Gynecologists. http://www.acog.org/~/media/ EC8117ABF5564928A740C4D1B3310E44.ashx. Accessed Sept. 1, 2013.
- Centers for Disease Control and Prevention, et al. Recommendations on the use of quadrivalent human papillomavirus vaccine in males — Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports. 2011:60;1705. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm. Accessed Oct. 1, 2013.
- Ali H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: National surveillance data. BMJ. 2013;346:f2032.
- Mikolajczyk RT, et al. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany — an ecologic study. Sexually Transmitted Diseases. 2013;40:28.
- Bauer HM, et al. Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: An analysis of California public family planning administrative claims data, 2007-2010. American Journal of Public Health. 2012;102:833.
- Macartney KK, et al. Safety of human papillomavirus vaccines: A review. Drug Safety. 2013;36:393.
- Rohren CH (expert opinion). Mayo Clinic, Rochester, Minn. Sept. 16, 2013.
- Gallenberg MM (expert opinion). Mayo Clinic, Rochester, Minn. Sept. 24, 2013.